BioXcel Therapeutics, Inc. (BTAIQ) Capital expenditures 2018–2025
BioXcel Therapeutics, Inc. (BTAIQ) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2018: $340,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | — |
| FY2024 | $0 | -100.0% |
| FY2023 | $20,000 | -85.6% |
| FY2022 | $139,000 | -68.8% |
| FY2021 | $445,000 | +40.8% |
| FY2020 | $316,000 | -63.7% |
| FY2019 | $870,000 | +155.9% |
| FY2018 | $340,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More BTAIQ financial trends
BTAIQ RevenueBTAIQ Net incomeBTAIQ Net marginBTAIQ Gross profitBTAIQ Gross marginBTAIQ Operating incomeBTAIQ Operating marginBTAIQ Operating cash flowBTAIQ Free cash flowBTAIQ Return on equityBTAIQ Stock buybacksBTAIQ Dividends paidBTAIQ Total assetsBTAIQ Total liabilitiesBTAIQ Shareholders’ equityBTAIQ overview →